Today: 7 February 2026
Subscribe

Cytokinetics (CYTK) Stock Hits 52-Week High as FDA Approval of Myqorzo Triggers Analyst Price-Target Hikes

Cytokinetics (CYTK) Stock Hits 52-Week High as FDA Approval of Myqorzo Triggers Analyst Price-Target Hikes

Cytokinetics, Incorporated (NASDAQ: CYTK) surged on Monday, December 22, 2025, extending a sharp rally that followed the company’s first-ever U.S. drug approval. Shares traded around $69.68 in the session, up roughly 11% from the prior close, after reaching an intraday high near $70.86—a move that pushed the biotech to fresh 52-week highs and re-focused Wall Street on the commercial potential of its newly approved heart drug, Myqorzo (aficamten). Investing.com The immediate catalyst is straightforward: the U.S. Food and Drug Administration approved Myqorzo on December 19, 2025 for adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). But the market reaction on December
22 December 2025
·
Citigroup Stock Hits a Fresh 52-Week High as Regulators Ease Oversight and Wall Street Updates 2026 Outlook

Citigroup Stock Hits a Fresh 52-Week High as Regulators Ease Oversight and Wall Street Updates 2026 Outlook

Dec. 22, 2025 — Citigroup Inc. (NYSE: C) is ending the year with momentum. In Monday trading, Citigroup stock pushed to a new 52‑week high and traded around $118, extending a powerful 2025 rally that has been driven by a mix of turnaround execution, capital return, and—most recently—regulatory overhang starting to lift. Investing.com+1 For investors trying to separate signal from noise, today’s Citi story is less about a single headline and more about a cluster of developments that collectively support the “simplification + risk-control repair + returns” thesis CEO Jane Fraser has been selling for years—now with outside validation from
22 December 2025
·
Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025

Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025

Amgen Inc. (NASDAQ: AMGN) is back in the spotlight on Monday, December 22, 2025, as investors weigh a wave of White House drug‑pricing agreements, a fast‑moving “most‑favored‑nation” (MFN) pricing push, and what it could all mean for Amgen’s earnings power in 2026. The stock traded higher in Monday’s session, with market data showing shares around $331. While the headlines are centered on drug prices, the market’s reaction has been notably measured: several analyst notes published today suggest these deals may be designed to reduce political and tariff uncertainty more than they materially compress pharma profits—at least in the near term.
22 December 2025
··
Quantum Computing Inc (QUBT) Stock News Today: Why Shares Jumped on Dec. 22, 2025 — and What Analysts Forecast Next

Quantum Computing Inc (QUBT) Stock News Today: Why Shares Jumped on Dec. 22, 2025 — and What Analysts Forecast Next

Quantum Computing Inc. (Nasdaq: QUBT) is back in the spotlight on Monday, Dec. 22, 2025, after a sharp intraday rally that highlights both the promise—and the peril—of the public “pure-play quantum” trade. As of the latest available trade data Monday, QUBT was around $12.39, up roughly 13.8% on the day, after opening near $10.93 and trading between $10.86 and $12.54. Trading volume topped 17 million shares, underscoring how quickly sentiment can swing in this name. So what’s driving the move, what did the latest company filings actually say, and how are analysts framing the stock heading into 2026? What happened
22 December 2025
····
Rigetti Computing Stock (RGTI) News Today, Dec. 22, 2025: Shares Surge as Analyst Forecasts for 2026 Focus on Roadmap, Cash Runway, and High-Volatility Risks

Rigetti Computing Stock (RGTI) News Today, Dec. 22, 2025: Shares Surge as Analyst Forecasts for 2026 Focus on Roadmap, Cash Runway, and High-Volatility Risks

Rigetti Computing, Inc. (NASDAQ: RGTI) is back in the spotlight on Monday, December 22, 2025, as quantum-computing stocks regain momentum. RGTI traded around $27 in Monday’s session, up roughly 14% on the day—another reminder that quantum “pure plays” can move fast in both directions. Finviz The renewed attention isn’t coming from a single headline. Instead, it’s being driven by a dense cluster of fresh stock-focused commentary published today—including a Zacks deep dive into estimates and valuation, a TipRanks roundup of what Wall Street expects for 2026, and a Motley Fool/Nasdaq comparison of Rigetti versus IonQ. Finviz+2TipRanks+2 Below is a detailed
22 December 2025
··
Firefly Aerospace Stock (NASDAQ: FLY) Jumps on Russell Index Addition: Today’s News, Analyst Forecasts, and Lawsuit Updates (Dec. 22, 2025)

Firefly Aerospace Stock (NASDAQ: FLY) Jumps on Russell Index Addition: Today’s News, Analyst Forecasts, and Lawsuit Updates (Dec. 22, 2025)

Firefly Aerospace Inc. (NASDAQ: FLY) stock is back in the spotlight on December 22, 2025, with shares trading around $28 and posting a mid-session gain of roughly 14% after hitting an intraday high near $28.30 on elevated volume. Investing.com The day’s action is being shaped by two very different forces: a visibility-boosting index milestone (Firefly’s addition to major Russell indexes) and a renewed wave of securities-litigation headlines circulating across newswires. Together, they’re amplifying both attention and volatility—exactly the kind of mix that can make a young, newly public aerospace name move fast in either direction. Why Firefly Aerospace stock is
22 December 2025
·
Qualcomm (QCOM) Stock News Today: Alphawave Semi Deal, Analyst Targets, and the Biggest 2026 Catalysts

Qualcomm (QCOM) Stock News Today: Alphawave Semi Deal, Analyst Targets, and the Biggest 2026 Catalysts

December 22, 2025 — QUALCOMM Incorporated (NASDAQ: QCOM) stock is trading modestly higher in Monday’s session, as investors weigh a fresh batch of deal headlines and Wall Street target updates against a bigger question: can Qualcomm’s diversification story (AI data centers, AI PCs, automotive, edge) keep accelerating as smartphone growth normalizes? Below is a detailed, publication-ready roundup of the latest QCOM stock news, forecasts, and analyses available as of 22.12.2025, with a focus on what matters most for the next 6–12 months. QCOM stock price check: where Qualcomm shares stand on Dec. 22 Qualcomm shares were last indicated around $175
22 December 2025
·
Hut 8 Stock (HUT) Jumps on Benchmark’s Street-High $85 Target as $7 Billion AI Data Center Deal Re-Rates the Story

Hut 8 Stock (HUT) Jumps on Benchmark’s Street-High $85 Target as $7 Billion AI Data Center Deal Re-Rates the Story

Hut 8 Corp. (Nasdaq: HUT; TSX: HUT) is back in the spotlight on Monday, December 22, 2025, as the company’s shares extend a sharp rally tied to its pivot from crypto-native infrastructure toward AI and high-performance computing (HPC) data centers. The latest catalyst: Benchmark raised its price target to a Street-high $85, arguing that Hut 8’s newly announced River Bend transaction marks a structural shift in the company’s revenue quality and durability. Investing.com+1 As of midday trading on Dec. 22, Hut 8 shares were up roughly 16% on the session, reflecting how quickly the market is repricing the company after
22 December 2025
··
Home Depot (HD) Stock Today: Latest News, Analyst Forecasts, and the 2026 Outlook Investors Are Pricing In (Dec. 22, 2025)

Home Depot (HD) Stock Today: Latest News, Analyst Forecasts, and the 2026 Outlook Investors Are Pricing In (Dec. 22, 2025)

Home Depot stock (NYSE: HD) is trading modestly higher on Monday, December 22, 2025, as investors weigh a steady stream of analyst commentary against the company’s recently reset expectations for 2026—a year management expects to remain closely tied to housing-market momentum and the timing of a recovery in bigger-ticket renovation spending. As of the latest update Monday afternoon (UTC), Home Depot shares were around $347, up roughly 0.7% on the day, with the session ranging roughly from the mid-$343s to the high-$347s. Home Depot stock price check: where HD trades on Dec. 22, 2025 Home Depot’s share price is still
22 December 2025
·
ABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes EffectABIVAXABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes Effect

ABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes EffectABIVAXABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes Effect

PARIS / NEW YORK — December 22, 2025 — ABIVAX Société Anonyme (Abivax SA) stock is back in the spotlight on Monday after renewed takeover chatter tied to U.S. pharma giant Eli Lilly—arriving the same morning Abivax’s addition to the Nasdaq Biotechnology Index (NBI) becomes effective. The combination is fueling a sharp move in ABVX shares and re-igniting debate about whether 2025’s biotech breakout is now morphing into an M&A (mergers and acquisitions) story. What’s happening with ABIVAX stock today (December 22, 2025) Abivax shares rose sharply in Monday trading as media reports revived speculation that Eli Lilly could be
22 December 2025
·
Alnylam Pharmaceuticals (ALNY) Stock on Dec. 22, 2025: Nasdaq-100 Debut, AMVUTTRA Momentum, Analyst Price Targets and the 2026 Outlook

Alnylam Pharmaceuticals (ALNY) Stock on Dec. 22, 2025: Nasdaq-100 Debut, AMVUTTRA Momentum, Analyst Price Targets and the 2026 Outlook

Dec. 22, 2025 — Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) is stepping into a new tier of market visibility today as its Nasdaq-100 Index membership takes effect ahead of the opening bell—an index catalyst that can influence near-term trading and broaden long-term institutional ownership. Nasdaq+1 ALNY was trading around $405.60 on Dec. 22 (time-stamped 16:37 UTC), up about 1.3% versus the prior close—an incremental move that nonetheless lands in the middle of a busier-than-usual news cycle for the RNAi leader. Below is a comprehensive roundup of the current news, forecasts, and market analysis circulating through Dec. 22, 2025, and what investors
22 December 2025
···
D-Wave Quantum Stock (QBTS) Jumps on CES 2026 Plans: News, Forecasts and Analysis (Dec. 22, 2025)

D-Wave Quantum Stock (QBTS) Jumps on CES 2026 Plans: News, Forecasts and Analysis (Dec. 22, 2025)

D-Wave Quantum Inc. (NYSE: QBTS) is back in the spotlight on December 22, 2025—and not in a subtle way. Shares surged in Monday trading as investors reacted to fresh company news tied to CES 2026, the technology mega-event in Las Vegas. As of the latest available quote, QBTS traded around $31.19, up roughly 16% on the session, after swinging between $27.15 and $31.41 with volume above 28 million shares. That headline pop is the “today story.” The bigger story—why D-Wave has become one of the most talked-about speculative tech names of 2025—sits at the intersection of quantum computing hype, real
22 December 2025
·
1 … 1,324 1,325 1,326 1,327 1,328 … 2,716

Stock Market Today

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026
Washington, Feb 7, 2026, 07:38 (EST) The IRS has not announced any new federal stimulus payments for February 2026, and Congress has not authorized another round of checks, Fox 5 DC reported. Online posts pushing $2,000 “tariff dividend” checks or other direct deposits have continued into 2026, sometimes mixing in state programs such as Alaska’s Permanent Fund Dividend, the report said. (fox5dc.com) The timing matters because tax filing season tends to put millions of people in “money-watching” mode. Refunds, credits and routine deposits hit bank accounts, and scammers try to ride the noise. President Donald Trump’s own comments have added
Go toTop